Number of Shares
2,974.00
Current Holdings Value*
$346,860.00
% of Portfolio
1.05%
Total Estimate Gain
$170,392.24
% of Total Estimate Gain
26.30%

Lazard US Small Cap Equity Select Portfolio's Axsome Therapeutics Inc Holding Summary

As of 2025-03-31, Lazard US Small Cap Equity Select Portfolio held 2,974.00 shares of Axsome Therapeutics Inc(AXSM), totaling $346,860.00. This investment constitutes 1.05% of their stock portfolio, and Lazard US Small Cap Equity Select Portfolio now holds 0.01% of the outstanding Axsome Therapeutics Inc(AXSM) stock.

The initial trade took place in 2024Q3. And since then Lazard US Small Cap Equity Select Portfolio has made 2 purchases of AXSM, at an average price of $87.96, for a total of 7,365.00 shares. In addition, there have been 1 sales at an average price of $113.93 for 4,391.00 shares. Based on historical transaction data and AXSM's current price of $106.91, Lazard US Small Cap Equity Select Portfolio's estimated gain on his AXSM holdings is $170,392.24, reflecting a 26.30% gain to date.

Lazard US Small Cap Equity Select Portfolio AXSM ($106.91) Holding Chart

Lazard US Small Cap Equity Select Portfolio AXSM ($106.91) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1